Publications in collaboration with researchers from Medical College of Wisconsin (4)

2025

  1. Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease

    Brain, Behavior, and Immunity, Vol. 128, pp. 600-611

2017

  1. Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks

    Neuroscience and Biobehavioral Reviews, Vol. 76, pp. 380-395

2016

  1. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease

    Brain, Behavior, and Immunity, Vol. 57, pp. 94-105

2014

  1. The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model

    Neurobiology of Aging, Vol. 35, Núm. 11, pp. 2603-2616